These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
490 related items for PubMed ID: 6800651
21. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines. Dorr RT, Liddil JD, Gerner EW. Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379 [Abstract] [Full Text] [Related]
22. Effects of dicyclohexylamine sulfate, a spermidine synthase inhibitor, in 9L rat brain tumor cells. Feuerstein BG, Deen DF, Marton LJ. Cancer Res; 1985 Oct; 45(10):4950-4. PubMed ID: 3928144 [Abstract] [Full Text] [Related]
23. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine. Seidenfeld J, Block AL, Komar KA, Naujokas MF. Cancer Res; 1986 Jan; 46(1):47-53. PubMed ID: 3079590 [Abstract] [Full Text] [Related]
24. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration. Kallio A, Seppänen P, Alhonen-Hongisto L, Jänne J. Cancer Res; 1983 Jan; 43(1):324-7. PubMed ID: 6401167 [Abstract] [Full Text] [Related]
25. Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine. Bjerkvig R, Oredsson SM, Marton LJ, Linden M, Deen DF. Cancer Res; 1983 Apr; 43(4):1497-500. PubMed ID: 6403224 [Abstract] [Full Text] [Related]
26. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Marton LJ, Levin VA, Hervatin SJ, Koch-Weser J, McCann PP, Sjoerdsma A. Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258 [Abstract] [Full Text] [Related]
27. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Takigawa M, Enomoto M, Nishida Y, Pan HO, Kinoshita A, Suzuki F. Cancer Res; 1990 Jul 01; 50(13):4131-8. PubMed ID: 1693880 [Abstract] [Full Text] [Related]
28. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Kingsnorth AN, King WW, Diekema KA, McCann PP, Ross JS, Malt RA. Cancer Res; 1983 Jun 01; 43(6):2545-9. PubMed ID: 6406047 [Abstract] [Full Text] [Related]
29. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO). Mivechi NF, Dewey WC, Feuerstein BG, Deen DF, Marton LJ. Radiat Res; 1986 Dec 01; 108(3):269-81. PubMed ID: 3099327 [Abstract] [Full Text] [Related]
30. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation. Stoscheck CM, Erwin BG, Florini JR, Richman RA, Pegg AE. J Cell Physiol; 1982 Feb 01; 110(2):161-8. PubMed ID: 6802862 [Abstract] [Full Text] [Related]
31. Reduction in cis-diamminedichloroplatinum(II)-induced cytotoxicity, sister chromatid exchange, and DNA interstrand cross-links in 9L cells treated with the polyamine biosynthesis inhibitor (2R,5R)-6-heptyne-2,5-diamine. Milam KM, Hunter KJ, Deen DF, Marton LJ. Cancer Res; 1989 Dec 15; 49(24 Pt 1):6945-8. PubMed ID: 2582436 [Abstract] [Full Text] [Related]
32. Delayed sensitization to heat by inhibitors of polyamine-biosynthetic enzymes. Fuller DJ, Gerner EW. Cancer Res; 1982 Dec 15; 42(12):5046-9. PubMed ID: 6814750 [Abstract] [Full Text] [Related]
33. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. Slotkin TA, Persons D, Slepetis RJ, Taylor D, Bartolome J. Teratology; 1984 Oct 15; 30(2):211-24. PubMed ID: 6208628 [Abstract] [Full Text] [Related]
34. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine. Casero RA, Go B, Theiss HW, Smith J, Baylin SB, Luk GD. Cancer Res; 1987 Aug 01; 47(15):3964-7. PubMed ID: 3038303 [Abstract] [Full Text] [Related]
35. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells. Zwelling LA, Kerrigan D, Marton LJ. Cancer Res; 1985 Mar 01; 45(3):1122-6. PubMed ID: 2982483 [Abstract] [Full Text] [Related]
36. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs. Gillespie MN, Dyer KK, Olson JW, O'Connor WN, Altiere RJ. Res Commun Chem Pathol Pharmacol; 1985 Dec 01; 50(3):365-78. PubMed ID: 3936139 [Abstract] [Full Text] [Related]
37. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response. Singh AB, Thomas TJ, Thomas T, Singh M, Mann RA. Cancer Res; 1992 Apr 01; 52(7):1840-7. PubMed ID: 1551114 [Abstract] [Full Text] [Related]
38. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma. Grossie VB, Ota DM, Ajani JA, Nishioka K. Cancer Res; 1987 Apr 01; 47(7):1836-40. PubMed ID: 3102050 [Abstract] [Full Text] [Related]
39. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats. Manni A, Badger B, Glikman P, Bartholomew M, Santner S, Demers L. Cancer Res; 1989 Jul 01; 49(13):3529-34. PubMed ID: 2499419 [Abstract] [Full Text] [Related]
40. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. Slotkin TA, Grignolo A, Whitmore WL, Lerea L, Trepanier PA, Barnes GA, Weigel SJ, Seidler FJ, Bartolome J. J Pharmacol Exp Ther; 1982 Sep 01; 222(3):746-51. PubMed ID: 6125588 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]